| #23 |
John M. Lambert |
Dana-Farber Cancer Institute |
1 |
| #23 |
Moses J. Folkman |
Children'S Medical Center |
1 |
| #23 |
Nathan Siemers |
Bristol-Myers Squibb |
1 |
| #23 |
Nigel Stewart Foster |
Itt |
1 |
| #23 |
Charles S. Naiman |
Bio-Lok International |
1 |
| #23 |
Sava Cvek |
Stylex |
1 |
| #23 |
Timothy Kelly |
Fusion Optix |
1 |
| #23 |
W. David Lee |
Lumicell |
1 |
| #23 |
Aloysius O. Anaebonam |
Ascent Pharmaceuticals |
1 |
| #23 |
J. Allan Hobson |
Harvard University |
1 |
| #23 |
Michael S. H. Chu |
Boston Scientific Scimed |
1 |
| #23 |
William F. Ganong, III |
Microsoft |
1 |
| #23 |
Marc Joshua Tolkoff |
Boston Scientific Limited |
1 |
| #23 |
Walter A. Blattler |
Immunogen |
1 |
| #23 |
Shai Inbar |
Pb Diagnostic Systems |
1 |
| #23 |
Aldo Morelli |
— |
1 |
| #23 |
Oleg Pomerantzeff |
Eye Research Institute Of Retina Foundation |
1 |
| #23 |
C. Hall Swaim |
— |
1 |
| #23 |
Isidore Philosophe |
Cinram Group |
1 |
| #23 |
Rodomir Lagushenko |
Gte Products |
1 |
| #23 |
Margaret Palau |
— |
1 |
| #23 |
Jason Vavlitis |
— |
1 |
| #23 |
Ross A. Nitkin |
— |
1 |
| #23 |
Alexander Gimpelson |
IBM |
1 |
| #23 |
Harvey Z. Kertzman |
— |
1 |
| #23 |
Mark J Tolkoff |
Medi-Tech Co. |
1 |
| #23 |
Harvey P. Greenspan |
— |
1 |
| #23 |
Kathleen Wardwell |
Ortho Pharmaceutical |
1 |
| #23 |
Philip S. Sleeman |
C.R. Bard |
1 |
| #23 |
Ruth Silberman-Hazony |
SUNY Research Foundation |
1 |
| #23 |
Michael Klibaner |
Angio-Medical |
1 |
| #23 |
Pasawadee Pradipasena |
MIT |
1 |
| #23 |
Patrick E. Prange |
Bull Hn Information Systems |
1 |
| #23 |
Gregory Khinchuk |
— |
1 |
| #23 |
Jean D. Sipe |
Boston University |
1 |
| #23 |
John J. Toole |
Genetics Institute |
1 |
| #23 |
George Bekefi |
MIT |
1 |
| #23 |
Tobin N. Gerhart |
Beth Israel Hospital Association |
1 |
| #23 |
Habib Al-Sioufi |
— |
1 |